Check out our most popular compounded medications! Get Started
Betamethasone 0.05% Ultrasound Gel is a clear or tinted gel-like substance specifically formulated to enhance ultrasonic transmission between the transducer and the skin during ultrasound examinations or therapeutic procedures. This formulation facilitates optimal imaging quality and improves the efficiency of ultrasound waves for diagnostic or therapeutic purposes.
It is used in the treatment of inflammatory skin conditions, such as dermatitis and psoriasis, by delivering anti-inflammatory effects directly to the affected area, thereby reducing swelling, redness, and itching.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Betamethasone 0.05% Ultrasound Gel is a compounded preparation that combines the potent anti-inflammatory properties of betamethasone with a specially formulated ultrasound gel base. This gel is designed to enhance ultrasonic transmission between the ultrasound transducer and the skin during examinations or therapeutic procedures. By facilitating optimal imaging quality, it not only improves the efficiency of ultrasound waves but also allows for the targeted delivery of betamethasone to the affected area.
When used in conjunction with ultrasound therapy, this formulation may enhance the transdermal absorption of betamethasone, potentially providing localized relief from inflammation and pain. The gel's composition ensures excellent contact with the skin, reducing air pockets that can interfere with the transmission of ultrasound waves and thereby maximizing the therapeutic benefits of the treatment.
The gel is applied directly to the skin, and the ultrasound waves help to drive the medication deeper into the tissues, which may lead to a more rapid onset of relief.
Prescribers might consider this formulation for patients who are undergoing ultrasound therapy and could benefit from the added anti-inflammatory effects of betamethasone. It offers a convenient way to deliver medication directly to the site of concern without the need for oral administration, potentially reducing systemic side effects.
Patients should be aware that while topical application of betamethasone generally has a lower risk of systemic side effects compared to oral steroids, it is still important to use the gel as directed. Possible side effects may include localized skin irritation or allergic reactions. If any adverse reactions occur, patients should inform their healthcare provider promptly.
Before prescribing this formulation, healthcare providers should assess the patient's medical history for any contraindications to corticosteroid use, such as skin infections or certain systemic conditions. It is also important to consider potential interactions with other medications the patient may be taking.
If you have any questions, please reach out to us.
Betamethasone 0.05% Ultrasound Gel is a topical corticosteroid formulation designed to enhance ultrasonic transmission during diagnostic or therapeutic ultrasound procedures. While this gel is primarily used to improve the efficiency of ultrasound waves, it also provides anti-inflammatory and immunosuppressive effects due to the presence of betamethasone. This can be beneficial in treating inflammatory skin conditions, such as dermatitis or psoriasis, when used in conjunction with ultrasound therapy. However, it is important to consider potential drug interactions when using this formulation.
Patients and prescribers should be aware that the systemic absorption of betamethasone from topical application is generally low, but it can increase if the gel is applied over large areas of the body, used for prolonged periods, or if occlusive dressings are used. This increased absorption can potentially lead to interactions with other medications. For instance, concurrent use of other corticosteroids, whether systemic or topical, may enhance the risk of systemic corticosteroid side effects, such as adrenal suppression, Cushing's syndrome, or hyperglycemia. Patients on long-term corticosteroid therapy should be monitored closely for these effects.
Betamethasone may also interact with medications that affect the cytochrome P450 enzyme system, particularly CYP3A4 inhibitors such as ketoconazole, itraconazole, or ritonavir. These medications can increase the plasma concentration of betamethasone, potentially leading to enhanced systemic effects. Conversely, CYP3A4 inducers like rifampin or phenytoin may decrease the effectiveness of betamethasone by increasing its metabolism. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements, to assess the risk of interactions.
Additionally, patients with pre-existing conditions such as diabetes, hypertension, or osteoporosis should use this formulation with caution, as corticosteroids can exacerbate these conditions. It is crucial for prescribers to evaluate the patient's medical history and current medication regimen to minimize the risk of adverse interactions and side effects. Patients should be advised to report any unusual symptoms or side effects to their healthcare provider promptly.
If you have any questions or need further information about the use of Betamethasone 0.05% Ultrasound Gel, please reach out to us. Our team of compounding pharmacists at Bayview Pharmacy is here to assist you with any concerns or inquiries you may have regarding this formulation and its potential interactions.
Betamethasone 0.05% Ultrasound Gel is a specialized formulation designed to serve dual purposes: enhancing ultrasonic transmission and delivering anti-inflammatory effects. This gel is a clear or tinted gel-like substance that is specifically crafted to improve the contact between the ultrasound transducer and the skin. By doing so, it facilitates optimal imaging quality and enhances the efficiency of ultrasound waves during diagnostic or therapeutic procedures.
In addition to its role in ultrasound procedures, this formulation contains betamethasone, a potent corticosteroid known for its anti-inflammatory and immunosuppressive properties. Betamethasone works by inhibiting the release of substances in the body that cause inflammation, thereby reducing swelling, redness, and itching. When used in conjunction with ultrasound therapy, the gel can help in the treatment of various inflammatory conditions by delivering the corticosteroid directly to the affected area, enhancing its therapeutic effects. This dual-action approach not only aids in precise imaging but also provides localized treatment for inflammatory conditions, potentially improving patient outcomes.
For patients, the use of Betamethasone 0.05% Ultrasound Gel can mean a more comfortable and effective ultrasound experience, with the added benefit of targeted anti-inflammatory treatment. For prescribers, this formulation offers a versatile tool that can be used in a variety of clinical settings, from diagnostic imaging to therapeutic interventions for inflammatory conditions. The gel's ability to enhance ultrasound transmission while simultaneously delivering medication makes it a valuable option in the management of conditions that benefit from both imaging and localized corticosteroid therapy.
If you have any questions about Betamethasone 0.05% Ultrasound Gel, its uses, or how it might benefit your specific situation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you with any inquiries or concerns you may have.
Betamethasone 0.05% Ultrasound Gel is used to enhance ultrasonic transmission between the transducer and the skin during ultrasound examinations or therapeutic procedures. It facilitates optimal imaging quality and improves the efficiency of ultrasound waves for diagnostic or therapeutic purposes.
The gel acts as a coupling agent, reducing air gaps between the transducer and the skin, which enhances the transmission of ultrasound waves. The inclusion of Betamethasone, a corticosteroid, may also provide anti-inflammatory benefits during therapeutic procedures.
While the gel is generally safe for most skin types, individuals with known allergies to corticosteroids or any other components of the gel should avoid its use. It is always recommended to perform a patch test or consult with a healthcare professional before use.
Potential side effects may include skin irritation or allergic reactions, particularly in individuals sensitive to corticosteroids. If any adverse reactions occur, discontinue use and consult a healthcare professional.
Apply a sufficient amount of gel to the area of the skin where the ultrasound transducer will be placed. Ensure even coverage to maximize contact and transmission of ultrasound waves.
Yes, this gel is compatible with most ultrasound machines. However, it is always advisable to check the manufacturer's guidelines for specific compatibility requirements.
The gel may be clear or tinted. Tinted gels can help practitioners see where the gel has been applied, ensuring even coverage and optimal ultrasound transmission.
Store the gel in a cool, dry place away from direct sunlight. Ensure the container is tightly closed when not in use to maintain the gel's efficacy and prevent contamination.
It is generally not recommended to use the gel on broken or damaged skin, as this may increase the risk of irritation or adverse reactions. Consult a healthcare professional for guidance in such cases.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
